NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein
Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer
Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call
Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value
ChanTest Acquires Applied Cell Sciences
Bio-Matrix Scientific Group Featured as 'Stock Pick' in Oakley's Column on WallStreetCorner.com
Prous Institute Presents Innovative Approach to Drug Discovery
ERT Reports Fourth Quarter and Full Year 2008 Results
From eResearchTechnology to ERT
Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.